Objectives: - Get familiarized with biohacking, a DIY (Do-It-Yourself) practice that employes the knowledge of multiple fields to enhance overall health, well-being, performance, and prolongment of healthspan.
- Learn about history, types, detailing and substantiation of biohacking, supplementation and medically prescribed biohacking, ethics, questions, gaps, barriers and reflections on biohacking
- Embrace and lead the biohacking movement, and take awareness and educate other healthcare providers.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Present the relevance of the microbiome on healthy and unhealthy aging

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Describe what is DNA methylation (Epigenetic aging), and how inflammation is associated with DNA aging. Show the final results of the clinical trial where patients with severe psoriasis were treated with Ilumya (tildrakizumab-asmn), anti-IL-23, in regards to possibility of reversal of epigenetic aging by improving inflammation.

Introduction: The complex interplay of genetic and environmental factors in psoriasis may occur through the epigenetic mechanisms. DNA methylation of cytosine followed by guanine residues (CpG dinucleotides), the epigenetic process that participates in the transcriptional regulation and gene expression, has been linked to psoriasis. As the precise pathogenesis underlying the development of psoriasis remains largely undefined, further exploration of the role of epigenetics would offer a biologically plausible perspective to clarify psoriasis etiology.

Materials / method: Design: Single-center open-label clinical trial.
Objective: Evaluate if tildrakizumab reverses peripheral blood leukocyte DNA methylation (epigenetic aging) observed in chronic psoriasis.
Number of subjects: 30. Intervention group: 20 (10 men, 10 women) with moderate-to-severe psoriasis. Control group: 10 (5 men, 5 women) with other skin diagnosis.
Population: >35-year-old subjects will be recruited from Brown Dermatology clinics.

Results: Results include the epigenetic aging and deep transcriptome analysis.

Conclusion: Reversal of epigenetic aging may lead to improved protein synthesis.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): SunPharma

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability